ORMP insider trading
NasdaqCM HealthcareORAMED PHARMACEUTICALS INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Company website: www.oramed.com
ORMP insider activity at a glance
FilingIQ has scored 230 insider transactions for ORMP since Feb 23, 2015. The most recent filing in our index is dated Mar 30, 2026.
Across the full history, 28 open-market purchases
and 17 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ORMP insider trades is 53.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
13F funds holding ORMP
Politicians who have traded ORMP
Frequently asked
- How many insider trades does FilingIQ track for ORMP?
- FilingIQ tracks 230 Form 4 insider transactions for ORMP (ORAMED PHARMACEUTICALS INC.), covering filings from Feb 23, 2015 onwards. 7 of those were filed in the last 90 days.
- Are ORMP insiders net buyers or net sellers?
- Across the full Form 4 history for ORMP, 28 transactions (12%) were open-market purchases and 17 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ORMP insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ORMP in?
- ORAMED PHARMACEUTICALS INC. (ORMP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $132.45M.
Methodology & sources
Every ORMP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.